Advertisement

A Randomized, Controlled Trial of Oxycodone Versus Placebo in Patients With PostHerpetic Neuralgia and Painful Diabetic Neuropathy Treated With Pregabalin

Published:December 04, 2009DOI:https://doi.org/10.1016/j.jpain.2009.09.003

      Abstract

      The aim of this randomized double-blind, placebo-controlled, parallel-group study was to evaluate the efficacy, safety, and tolerability of pregabalin in combination with oxycodone or placebo, in patients with either postherpetic neuralgia (PHN) or painful diabetic neuropathy (PDN). After a 7-day washout period, 62 patients were randomized to receive either oxycodone mixture 10 mg/day or placebo mixture for 1 week. Patients were then started on open-label pregabalin (75, 150, 300 and 600 mg/day) according to a forced titration dosing regimen, while continuing the same dosage of oxycodone or placebo for 4 weeks. The primary efficacy measure was a decrease in the pain-intensity score of at least 2cm and a pain score <4cm measured using a 10-cm visual analogue scale (VAS) following pregabalin dosage escalation and treatment for 4 weeks. Secondary efficacy measures included sleep interference and the Neuropathic Pain Scale. There were similar levels of overall efficacy between pregabalin/oxycodone and pregabalin/placebo groups in relieving PHN and PDN related pain.

      Perspective

      Peripheral neuropathic pain presents commonly in clinical practice, and 2 of its most prevalent types are PHN and PDN. Currently available treatments provide some degree of pain relief in ∼40-60% of patients, leaving the remainder with unremitting pain. Although this study supports the effectiveness of pregabalin in the treatment of PHN or PDN, it also shows that the addition of a low dose of oxycodone at 10mg/day does not enhance the pain-relieving effects of pregabalin.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Baron R.
        Mechanisms of disease: neuropathic pain - a clinical perspective.
        Nat Clin Pract Neurol. 2006; 2: 95-106
        • Belliotti T.R.
        • Capiris T.
        • Ekhato I.V.
        • Kinsora J.J.
        • Field M.J.
        • Heffner T.G.
        • Meltzer L.T.
        • Schwarz J.B.
        • Taylor C.P.
        • Thorpe A.J.
        • Vartanian M.G.
        • Wise L.D.
        • Zhi-Su T.
        • Weber M.L.
        • Wustrow D.J.
        Structure-activity relationships of pregabalin and analogues that target the alpha(2)-delta protein.
        J Med Chem. 2005; 48: 2294-2307
        • Dworkin R.H.
        • Backonja M.
        • Rowbotham M.C.
        • Allen R.R.
        • Argoff C.R.
        • Bennett G.J.
        • Catherine Bushnell M.
        • Farrar J.T.
        • Galer B.S.
        • Haythornthwaite J.A.
        • Hewitt D.J.
        • Loeser J.D.
        • Max M.B.
        • Saltarelli M.
        • Schmader K.E.
        • Stein C.
        • Thompson D.
        • Turk D.C.
        • Wallace M.S.
        • Watkins L.R.
        • Weisntein S.M.
        Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations.
        Arch Neurol. 2003; 60: 1524-1534
        • Dworkin R.H.
        • O'Connor A.B.
        • Backonja M.
        • Farrar J.T.
        • Finnerup N.B.
        • Jensen T.S.
        • Kalso E.J.
        • Loeser J.D.
        • Miaskowski C.
        • Nurmiko T.J.
        • Portenoy R.K.
        • Rice A.S.C.
        • Stacey B.R.
        • Treede R.D.
        • Turk D.C.
        • Wallace M.S.
        Pharmacologic management of neuropathic pain: Evidence-based recommendations.
        Pain. 2007; 132: 237-251
        • Farrar J.T.
        • Young J.P.
        • LaMoreaux L.
        • Werth J.L.
        • Poole R.M.
        Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
        Pain. 2001; 94: 149-158
        • Fazen L.E.
        • Ringkamp M.
        The pathophysiology of neuropathic pain: A review of current research and hypotheses.
        Neurosurg Q. 2007; 17: 245-262
        • Fink K.
        • Dooley D.J.
        • Meder W.P.
        • Suman-Chauhan N.
        • Duffy S.
        • Clusmann H.
        • Gothert M.
        Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex.
        Neuropharmacology. 2002; 42: 229-236
        • Galer B.S.
        • Jensen M.P.
        Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale.
        Neurology. 1997; 48: 332-338
        • Gilron I.
        • Bailey J.M.
        • Tu D.S.
        • Holden R.R.
        • Weaver D.F.
        • Houlden R.L.
        Morphine, gabapentin, or their combination for neuropathic pain.
        N Engl J Med. 2005; 352: 1324-1334
        • Gimbel J.S.
        • Richards P.
        • Portenoy R.K.
        Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial.
        Neurology. 2003; 60: 927-934
        • Grosskopf J.
        • Mazzola J.
        • Wan Y.
        • Hopwood M.
        A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy.
        Acta Neurol Scand. 2006; 114: 177-180
        • Hanna M.
        • O'Brien C.
        • Wilson M.C.
        Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients.
        Eur J Pain. 2008; 12: 804-813
        • Hansson P.T.
        • Dickenson A.H.
        Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies.
        Pain. 2005; 113: 251-254
        • Harden R.N.
        Chronic neuropathic pain - mechanisms, diagnosis, and treatment.
        Neurologist. 2005; 11: 111-122
        • Jensen M.P.
        • Dworkin R.H.
        • Gammitoni A.R.
        • Olaleye D.O.
        • Oleka N.
        • Galer B.S.
        Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale.
        J Pain. 2005; 6: 98-106
        • Lee T.M.C.
        • Cheung C.C.Y.
        • Chan J.K.P.
        • Chan C.C.H.
        Trail making across languages.
        J Clin Exp Neuropsychol. 2000; 22: 772-778
        • Lesser H.
        • Sharma U.
        • LaMoreaux L.
        • Poole R.M.
        Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial.
        Neurology. 2004; 63: 2104-2110
        • Low P.A.
        • Dotson R.M.
        Symptomatic treatment of painful neuropathy.
        JAMA. 1998; 280: 1863-1864
        • Max M.
        Neuropathic pain syndromes.
        in: Max M. Portenoy R. Laska E. Advances in pain research and therapy, Vol 18. Raven Press Ltd, New York, NY1991: 193-219
        • McNair D.M.
        • Lorr M.
        • Droppleman L.F.
        Profile of mood states (POMS) manual.
        Educational and Industrial Testing Service, San Diego, CA1992 (pp 1-28)
        • Merskey H.
        • Bogduk N.
        Classification of Chronic Pain.
        2nd ed. IASP Press, Seattle, WA1994 (p 394)
        • Namaka M.
        • Gramlich C.R.
        • Ruhlen D.
        • Melanson M.
        • Sutton I.
        • Major J.
        A treatment algorithm for neuropathic pain.
        Clin Ther. 2004; 26: 951-979
        • Ostelo R.W.
        • de Vet H.C.
        Clinically important outcomes in low back pain.
        Best Pract Res Clin Rheumatol. 2005; 19: 593-607
        • Pappagallo M.
        • Haldey E.J.
        Pharmacological management of postherpetic neuralgia.
        CNS Drugs. 2003; 17: 771-780
        • Reuben S.S.
        • Connelly N.R.
        • Maciolek H.
        Postoperative analgesia with controlled-release oxycodone for outpatient anterior cruciate ligament surgery.
        Anesth Analg. 1999; 88: 1286-1291
        • Rice A.S.
        • Maton S.
        Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study.
        Pain. 2001; 94: 215-224
        • Richter R.W.
        • Portenoy R.
        • Sharma U.
        • Lamoreaux L.
        • Bockbrader H.
        • Knapp L.E.
        Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial.
        J Pain. 2005; 6: 253-260
        • Rosenstock J.
        • Michael T.B.
        • LaMoreaux L.
        • Sharma U.
        Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial.
        Pain. 2004; 110: 628-638
        • Rowbotham M.
        • Harden N.
        • Stacey B.
        • Berstein P.
        • Magnus-Miller L.
        Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial.
        JAMA. 1998; 280: 1837-1842
        • Salaffi F.
        • Stancati A.
        • Silvestri C.A.
        • Ciapetti A.
        • Grassi W.
        Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale.
        Eur J Pain. 2004; 8: 283-291
        • Schmader K.E.
        Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy.
        Clin J Pain. 2002; 18: 350-354
        • Spreen O.
        • Strauss E.
        A compendium of neuropsychological tests.
        2nd ed. Oxford University Press, New York, NY1998 (pp 533-547)
        • Sunshine A.
        • Olson N.Z.
        • Colon A.
        • Rivera J.
        • Kaiko R.F.
        • Fitzmartin R.D.
        • Reder R.F.
        • Goldenheim P.D.
        Analgesic efficacy of controlled-release oxycodone in postoperative pain.
        J Clin Pharmacol. 1996; 36: 595-603
        • Ware J.E.
        • Sherbourne C.D.
        The Mos 36-Item Short-Form Health Survey (Sf-36) .1. Conceptual-framework and Item selection.
        Med Care. 1992; 30: 473-483
        • Watson C.P.N.
        • Babul N.
        Efficacy of oxycodone in neuropathic pain - a randomized trial in postherpetic neuralgia.
        Neurology. 1998; 50: 1837-1841
        • Watson C.P.N.
        • Moulin D.
        • Watt-Watson J.
        • Gordon A.
        • Eisenhoffer J.
        Controlled-release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy.
        Pain. 2003; 105: 71-78
        • Woolf C.J.
        • Decosterd I.
        Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients.
        Pain. 1999; 6: S141-S147
        • Zin C.S.
        • Nissen L.M.
        • Smith M.T.
        • O'Callaghan J.P.
        • Moore B.J.
        An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy.
        CNS Drugs. 2008; 22: 417-442